Figure 3.
Cardiovascular-related pharmacological therapies which may affect numbers and function of endothelial progenitor cells. TZDs: Thiazolidinedione; DPP4I: Dipeptidyl peptidase 4 inhibitors; ARBs: Angiotensin II receptor blockers; ACEI: Angiotensin converting enzyme inhibitors; CCBs: Calcium channel blockers.